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ABSTRACT
Toxicity of gamma irradiated mycotoxins aflatoxin B1 (AFB1) and ochratoxin A (OTA) was investi-
gated in vitro. AFB1 and OTA stock solutions (50mM, in methanol) were gamma irradiated (5 and
10 kGy) and non-irradiated and irradiated mycotoxins solutions were tested for cytotoxicity on
Pk15, HepG2 and SH-SY5Y cell lines (MTT assay, 1–500lM concentration range; 24h exposure).
Degradation of mycotoxin molecules was examined by liquid chromatography tandem mass spec-
trometry (HPLC-MS/MS). AFB1 and OTA radiolytic products were less toxic than the parent myco-
toxins to all of the tested cell lines. Gamma irradiation even at 5 kGy had effect on AFB1 and OTA
molecules however, this effect was dependent on chemical structure of mycotoxin. Since gamma
irradiation at low dose reduced initial level of both mycotoxins, and gamma irradiated mycotoxins
had lower toxicity in comparison to non-irradiated mycotoxins, it can be concluded that gamma
irradiation could be used as decontamination method.
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Introduction
Mycotoxins aflatoxin B1 (AFB1) and ochratoxin A (OTA)
have been found as contaminants of various commodities all
over the world.[1–3] Recent review article reported AFB1 con-
centrations in foodstuffs of up to 42 and 90lg/kg in Africa
and Asia, respectively, and OTA of up to 9lg/kg in Central
and South America and Europe, and 15lg/kg in Asia.[3]
Toxicity and carcinogenicity of AFB1 and OTA to experimen-
tal animals are well documented.[4] Due to proven carcino-
genicity to humans, International Agency for Research on
Cancer (IARC) classified AFB1 as a Group 1 carcinogen,
[5]
while OTA is classified into group 2B (possible human car-
cinogen).[6] To protect human and animal health the govern-
ments around the world set specific regulations for acceptable
concentrations of mycotoxins in food and feed. In the
European Union maximum levels and guidance values for
mycotoxins in food intended for human consumption have
been set by Commission Regulation (EU) 1881/2006 and
Commission Recommendation No 2013/165/EU.[7,8]
According to them for AFB1 maximum level in all cereals
and all products derived from cereals is set to 2.0lg/kg, while
for OTA maximum level in all products derived from unpro-
cessed cereals, including processed cereal products and cereals
intended for direct human consumption is set to 3.0lg/kg.[7]
To reduce mycotoxin contamination and consequently
human and animal exposure to them, several studies tested
gamma irradiation as decontamination method.[9–14]
Gamma irradiation is a physical method based on the ability
of high-energy photons generated by radiation of 60Co to
induce chemical changes of target molecule by causing its
degradation or remodelling. In mycotoxin molecules the
most prone to the interaction with high-energy photons
generated by radiation of 60Co are aromatic or heterocyclic
rings. Studies so far indicate that gamma irradiation can
reduce mycotoxin levels in various commodities. Gamma
irradiation at low dose (up to 6 kGy) reduced for around
90% AFB1 level in fruit and red chillies samples,
[9,12] and
dose of 10 kGy in maze seed samples reduced AFB1 level
for around 95%.[14] Similarly, gamma irradiation at dose of
10 kGy almost completely degraded OTA in coffee beans,[11]
and same dose (10 kGy) in dry-cured meat products
reduced OTA for around 22.5%.[13]
Although studies indicate that gamma irradiation could be
suitable decontamination method, data on toxicity of radio-
lytic products of mycotoxins (products formed by gamma
irradiation of mycotoxins) are lacking. Therefore, the aim of
this study was to test the toxicity of the parent mycotoxin
and its radiolytic products on three cell lines, Pk15, HepG2
and SH-SY5Y in order to mimic different target organs (kid-
ney, liver and brain). Additionally, degradation of mycotoxin
molecules was monitored by HPLC-MS/MS.
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Materials and methods
Gamma irradiation of mycotoxin stock solutions
Mycotoxins AFB1 and OTA (Sigma-Aldrich, St. Louis, MO,
USA) stock solutions at 50mM were prepared in methanol
and aliquoted in amber glass vials. For each mycotoxin, one
sample was not irradiated (non-irradiated sample, positive
mycotoxin control) and two samples were subjected to
gamma irradiation.
Mycotoxin stock solutions (in closed amber glass vials)
were gamma irradiated in a panoramic 60Co source at the
Radiation Chemistry and Dosimetry Laboratory, Rud-er
Boskovic Institute (Zagreb, Croatia). The radiation doses
were 5 and 10 kGy and the dose rate was 140Gy/min. The
dose rate was established using an ethanol-chlorobenzene
dosimetry system[15] and calculated daily taking into account
the radioactive decay of 60Co. The irradiation was performed
at ambient temperature (about 18 C) and ambient atmos-
phere of a gamma chamber.
HPLC-MS/MS analysis
HPLC-MS/MS analysis of non-irradiated and irradiated
AFB1 and OTA stock solutions was performed using an
HPLC (Infinity 1260, Agilent, Santa Clara, USA) coupled
with a triple quadrupole mass detector (6410, Agilent, Santa
Clara, USA). The mobile phase consisted of 0.1% formic
acid (in water) and acetonitrile, and the injection volume
was 1 lL. The mass spectrometry conditions were as follows:
electrospray ionisation (ESI), positive polarity, fragmentor
voltage 150 and 110 V for AFB1 and OTA, respectively,
capillary voltage 6 kV (þ), source temperature 350 C, nebu-
liser 45 psi and gas flow 5 L/min. The mass spectrometer
was operated in MS2 scan (full scan mode). Protonated
molecular ions of AFB1 at m/z¼ 313 and OTA at m/z¼ 404
were monitored.
Cell viability
Cell viability was determined by 3-(4,5-dimethylthiazolyl-2)-
2,5-diphenyltetrazoliumbromide (MTT assay; Sigma-Aldrich
St. Louis, MO, USA), using porcine kidney epithelial (Pk15),
human hepatoma (HepG2) and human neuroblastoma (SH-
SY5Y) cells. Cells were seeded in 96-well tissue culture plates
at a planting density of 8 104 cells/mL and maintained at
37 C in a humidified atmosphere of 5% CO2 and 95% of
air. Cells were treated with non-irradiated AFB1 or OTA
(mycotoxin positive control) or with AFB1 or OTA irradi-
ated at 5 or 10 kGy at final concentrations of 1–500 lM for
24 h. AFB1 and OTA stock solutions were prepared in
methanol; by diluting stock solutions in PBS buffer, the final
methanol concentration in the mycotoxin solutions for cell
treatment was less than 1% and did not affect cell viability.
In each experiment, a negative control (PBS-buffer treated)
and an MTT-positive control were included. After the treat-
ment, the cell medium was removed and cells incubated
with MTT solution at a final concentration of 0.5mg/mL.
After incubation (3 h, at 37 C in an atmosphere of 5% CO2
and 95% of air), formazan crystals were dissolved in
dimethyl sulfoxide (DMSO) and absorbance was read at
570 nm on a multilabel plate reader (VictorTM, PerkinElmer,
Walthman, MA, USA).
Statistical analysis
The results of cell viability of two independent sets of
experiments (each with minimum six replicates) are
expressed as mean percentage (%) ± SD, compared to nega-
tive control (PBS-treated cells, set at 100%). The differences
among treatments were tested by one-way analysis of vari-
ance (ANOVA) followed by a post hoc Tukey test using
Statistica software version 10.0 (StatSoft Inc. 1984-2011,
USA). The statistical significance was set at 95% (P¼ 0.05).
Results and discussion
Cytotoxicity of AFB1 and OTA
AFB1 was cytotoxic to all of the tested cell lines, SH-SY5Y,
Pk15 and HepG2 (Fig. 1). These results are in agreement
with previous studies that showed decreased cell survival
after treatment with AFB1.
[16–19] Cytotoxicity of AFB1 to
SH-SY5Y was recorded at 100 mM (reduction of cell viability
for 16 ± 1.2%; P< 0.05, compared to negative control; Fig.
1c), while AFB1 was cytotoxic to Pk15 only at 500lM
(reduction of cell viability for 35 ± 8.9%; P< 0.05, compared
to negative control; Fig. 1a). As expected, HepG2 cells were
the most sensitive to AFB1 treatment. A decrease in HepG2
viability (by 14 ± 7.8%; P< 0.05, compared to negative con-
trol; Fig. 1b) was observed even after the lowest applied
AFB1 concentration (1 lM). AFB1 is a well-documented hep-
atocarcinogen whose toxicity is mainly connected to its
metabolic activation and genotoxic metabolite formation.
Since AFB1 is predominantly metabolised in the liver, the
human hepatoma HepG2 cell model is considered to be the
most suitable system for testing its in vitro toxicity. This sys-
tem represents liver cells and includes a wide spectrum of
phase I and II enzyme activities enabling them to mimic
metabolic conditions of xenobiotics in the living organ-
ism.[20,21] The results on cell viability observed in our study
after treatment with AFB1 differ from studies by Costa
et al.,[22] Ghaderi et al.[23] and Liu et al.[24] This could be
attributed to different cell viability tests, exposure condi-
tions, culture medium as well as supplements added to the
medium. However, the results are comparable to the study
by Curcuera et al.[25] in which using the same assay (MTT)
similar IC50 on HepG2 cells for AFB1 was obtained (about
100 mM).
In this study OTA induced a decrease in cell viability to
all of the tested cell lines. The cytotoxicity of OTA to Pk-15,
HepG2 and SH-SY5Y was observed at a concentration of
50 lM (Fig. 2). However, a more pronounced toxic effect of
OTA (at concentration 50 lM) was recorded on SH-SY5Y
cells (reduction of cell viability for 31 ± 3.6%, P< 0.05, com-
pared to negative control; Fig. 2c) and HepG2 cells (reduc-
tion of cell viability for 25 ± 3.1%; P< 0.05, compared to
negative control; Fig. 2b), while kidney cells (Pk 15) seemed
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to be more resistant (reduction of cell viability for 13 ± 5.6%;
P< 0.05, compared to negative control; Fig. 2a). These
results are in agreement with Zhang et al.[26] who observed
on SH-SY5Y cells and primary neurons OTA toxicity at low
concentrations (0.25 lM and 0.5 lM, respectively). Since
their results were comparable to those obtained previously
by Hundhausen et al.[27] on hepatocytes, the authors con-
cluded that neurons could be equally susceptible to OTA as
hepatocytes. Moreover, the same authors, by comparing
their results to study conducted on kidney tubulus cells[28,29]
concluded that neurons may be even more susceptible to
OTA than kidney cells as is observed in our study. Curcuera
et al.[25] and Gayathari et al.[30] obtained a similar IC50 for
OTA on HepG2 as in our study (360 and 210lM, respect-
ively). Additionally, as in our study Curcuera et al.[25] found
that AFB1 was more toxic to HepG2 than OTA.
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Figure 1. Cell viability of: (A) Pk15 cells, (B) HepG2 cells, and (C) SH-SY5Y cells after treatment with non-irradiated aflatoxin B1 (AFB1, 1–500 mM, 24 h; solid black
columns) or gamma irradiated AFB1 at 5 or 10 kGy (1–500 mM, 24 h; AFB1-5 kGy, diagonally striped columns, AFB1-10 kGy, diagonally crossed columns); cell viability
is assessed with MTT test. The results are expressed as mean percentage (%) ± standard deviation, compared to negative control (PBS-treated cells, set at 100%;
solid white columns) of two independent set of experiments, each with six replicates; column represent mean value and error bar standard deviation. a - different
from negative control (PBS-control); b - different from respective non-irradiated control (AFB1-treated). One-way ANOVA followed by Tukey test (P< 0.05).
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Cytotoxicity of gamma irradiated AFB1 and OTA
Results on the cytotoxicity of gamma irradiated mycotoxins
demonstrated that radiolytic products of gamma irradiated
AFB1 and OTA in comparison to the parent mycotoxin
were less toxic to all of the cell lines tested. In comparison
to the parent molecules at the same concentration observed
reduction in toxicity of gamma irradiated mycotoxins to Pk-
15, HepG2 and SH-SY5Y cells was by around 20% (from 5
to 40%) (Figs. 1 and 2). For example, while non-irradiated
AFB1 at 100lM was cytotoxic to SH-SY5Y cells, AFB1 at
the same concentration (100lM) irradiated at 10 kGy was
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Figure 2. Cell viability of: (A) Pk15 cells, (B) HepG2 cells, and (C) SH-SY5Y cells after treatment with non-irradiated ochratoxin A (OTA, 1–500 mM, 24 h; solid black
columns) or irradiated OTA at 5 or 10 kGy (1–500 mM, 24 h; OTA-5 kGy, diagonally striped columns, OTA-10 kGy, diagonally crossed columns); cell viability is
assessed with MTT assay. The results are expressed as mean percentage (%) ± standard deviation, compared to negative control (PBS-treated cells, set at 100%; solid
white columns) of two independent set of experiments each with six replicates; column represent mean value and error bar standard deviation. (a) Different from
negative control (PBS-control); (b) Different from respective non-irradiated mycotoxin control (OTA-treated). One-way ANOVA followed by Tukey test (significant at
level P< 0.05).
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not toxic to SH-SY5Y cells, i.e. a complete reduction of
AFB1 toxicity (reduction by around 16%; P< 0.05, compared
to non-irradiated AFB1; Fig. 1c) was observed. These results
clearly indicate that gamma irradiation induced formation of
less toxic products than parent mycotoxin. In available lit-
erature there are only few studies on toxicity of gamma irra-
diated mycotoxins. In study of Kumar et al.,[11] human
intestinal epithelial (Int-407) cells were treated with gamma
irradiated OTA (at 10 kGy) and by applying the same MTT
assay an approximately 7-fold reduction of cytotoxicity of
irradiated OTA is observed. In recent study cytotoxicity of
gamma irradiated OTA (gamma irradiated to up to 10.3
kGy) was tested on HepG2 cells and 2-fold reduction of
OTA cytotoxicity (assessed by neutral red assay) was
observed.[31] The difference in reduction of cytotoxicity of
gamma irradiated OTA in above mentioned studies (7- and
2- fold) and in our study (only 20%) can be explained by
the process of gamma irradiation. Gamma irradiation is
more effective in reducing mycotoxin level when mycotoxin
is present in lower concentration and when sample has
higher moisture content.[10,32,33] Although gamma irradi-
ation of OTA for in vitro testing in the study of Kumar
et al.[11] and Calado et al.[31] is not clearly described, it
could be that they gamma irradiated OTA at lower
concentration.
Results of HPLC-MS/MS analysis of non-irradiated and
gamma irradiated mycotoxin solutions in our study revealed
that gamma irradiation even at 5 kGy had impact on both,
AFB1 and OTA. The signal intensity of AFB1 (AFB1 ion at
313.2 m/z) in AFB1 stock solution gamma irradiated at 5
kGy was reduced around 16 times compared to non-irradi-
ated AFB1 stock solution (0.2 106 vs. 3.2 106; Fig. 3). On
the other hand, the signal intensity of OTA (OTA ion at
404.2 m/z) was reduced only twice (3.2 105 vs. 7.2 105;
Fig. 4). In the mass spectra of irradiated AFB1 solutions ions
at 285.2, 345.2, 359.2, and 381.2 m/z were observed that
could have been the product of AFB1 degradation or mol-
ecule remodelling. Ions pointing to molecule degradation or
remodelling were not observed in the mass spectra of the
irradiated OTA solution probably due to low concentration
of these products reaching the instrument detection limit.
The lower level of AFB1 and OTA detected in irradiated
mycotoxin solutions confirmed that gamma irradiation has
impact on AFB1 and OTA. Observed difference in the effect
of gamma irradiation on AFB1 and OTA could be attributed
to their chemical structure.
HPLC-MS/MS analysis indicates that AFB1 molecule is
more susceptible to degradation and remodelling induced by
high-energy photons generated by 60Co than OTA. Different
mycotoxin susceptibility to gamma irradiation observed in
our study was previously reported by Mutler and Erkoc.[34]
They tested different aflatoxins and found that AFB1 was
the most radiosensitive and aflatoxin B2 the most resistant
to gamma irradiation. The high-energy photons generated
Figure 3. Mass spectra of aflatoxin B1 (AFB1) stock solutions (50mM): (A) non-irradiated, and (B) irradiated at 5 kGy dose.
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by 60Co can affect double bounds in aromatic or heterocyc-
lic rings in mycotoxin’s molecule. AFB1’s superior suscepti-
bility to gamma irradiation could be attributed to feasible
addition reaction on the 8,9 double bound in the furan ring
initiated by the free radicals generated during gamma irradi-
ation. This observation is confirmed by Wang et al.[33] In
study of Wang et al.[33] AFB1 was gamma irradiated (up to
10 kGy) and by HPLC-MS/MS analysis seven radiolytic
products of gamma irradiated AFB1 are identified and six of
them were considered less toxic that AFB1. In that study the
toxicity evaluation was based on the structure–activity rela-
tionship (SAR) analysis rather than on testing on live, in
vitro model as in our study. The authors considered radio-
lytic product in which the addition reaction occurred on the
double bond in the terminal furan ring less toxic than AFB1.
According to quantitative SAR studies, the furofuran moiety
of the AFB1 structure is essential for its toxicity and carcino-
genicity. It is demonstrated that the presence of double
bound in the terminal furan ring is important determinant
of AFB1 acute and chronic effects in rats.
[33,35,36] Therefore,
in our study the lower toxicity of AFB1 radiolytic products
could be explained by lower unsaturation or the number of
double-bonds in comparison to non-irradiated AFB1.
This study demonstrated that gamma irradiation (at 5
and 10 kGy) has an impact on both, AFB1 and OTA
molecules. Radiolytic products formed by gamma irradiation
of AFB1 and OTA are found to be less toxic to cells (Pk15,
HepG2, SH-SY5Y) than the parent compounds (non-irradi-
ated mycotoxins). Even low gamma irradiation dose (5 kGy)
reduced AFB1 and OTA levels as detected by HPLC-MS/MS.
However, AFB1 was more susceptible to gamma irradiation
than OTA. AFB1 radiolytic products are probably results of
addition reaction on double bound in the terminal furan
ring. The mechanism of OTA degradation is more complex
since its radiolytic products were not detected. Based on the
results of studies examining impact of gamma irradiation on
nutritional quality of food[37–39] international food organisa-
tions (FAO/IAEA/WHO)[40] concluded that gamma irradi-
ation dose of up to 10 kGy has no effects on nutritional
quality of food and has no adverse effect on human and ani-
mal health. Since in this study radiation up to 10 kGy was
applied, gamma irradiation can be considered an effective
and safe method for mycotoxin detoxification in the produc-
tion of food and feed.
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